OTCMarketsExpert
Long

Oncocyte corp attracts some bullish buyers pre earnings.

AMEX:OCX   ONCOCYTE CORP
Over the past few trading sessions AMEX:OCX has had some bullish price action as earnings approach on 14the Aug. Technically the indicators have reversed in a bullish fashion and buy-side volume has increased consistently.
AVERAGE ANALYSTS PRICE TARGET $7.15
AVERAGE ANALYSTS RECOMMENDATION BUY
P/E RATIO
SHORT INTEREST
COMPANY PROFILE
OncoCyte Corp. is a pharmaceutical company. It is focused on the discovery, development and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer. The company was founded in September 2009 and is headquartered in Alameda, CA.
Official TradingView Page For http://www.ResearchOTC.com & http://www.MomentumOTC.com. 🤑💰 Since 2009, we are the #1 Source for Serious Stock Picks for Serious Traders! 📈
Home Stock Screener Forex Screener Crypto Screener Economic Calendar How It Works Chart Features Pricing House Rules Moderators Website & Broker Solutions Widgets Charting Solutions Get Help Feature Request Blog & News FAQ Wiki Twitter
Profile Profile Settings Account and Billing Get Help Ideas Published Followers Following Private Messages Chat Sign Out